1 / 14

Pharmacovigilance Market ppt

The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research

mujawar
Download Presentation

Pharmacovigilance Market ppt

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Market  Report 2019-2027 www.emergenresearch.com . 2 Increasing incidence of drug toxicity and ADR (adverse drug reactions) are stimulating the market demand

  2. Our Model Market Analysis Financial Analysis Distribution Channel Analysis Brand Analysis Custom Market Intelligence Competitor Analysis Product Analysis Custom Research www.emergenresearch.com Demand Analysis Risk Analysis

  3. Business Plan Parameters End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility www.emergenresearch.com Customer Identification Survey Competitive Landscape / M&A Feasibility www.emergenresearch.com

  4. Industries We Cater to Food & Beverages Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Power & Energy Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy Automotive Services Information and Tech Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce www.emergenresearch.com Pharma & Healthcare Materials and Chemicals Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings 5

  5. Market Summary The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research. The market for pharmacovigilance is experiencing rapid growth attributed to a rise in application for spontaneous reporting, electronic health record (HER) mining, cohort event monitoring, and intensified adverse drug reaction (ADR) reporting, among others. The pharmacovigilance primarily emphasizes on on ADR (adverse drug reactions) and cases of drug toxicity. According to the statistic released by WHO, about 5.0% of hospitalized patients in the developed nations are admitted into the hospital due to adverse drug reactions, and 6.0% to 10% of in-patients are anticipated to observe a severe adverse reaction for the duration of hospitalization. A rise in demand for outsourcing services by players in the healthcare industry is anticipated to boost the forecast period's pharmacovigilance market growth. A spiraling inclination to outsource eliminates the issues pertaining to overhead costs and the pharmacovigilance resources’ deployment. Outsourcing is beneficial in enhancing the cost-effectiveness and output efficiency by releasing pressure associated with the procurement of resources on firms, therefore encouraging market growth. Leading pharmaceutical firms are substantially involved in extensive R&D ingenuities for novel therapeutic drug molecules to get superior outcomes, thereby successfully leading to a rise in drug development activities. www.emergenresearch.com

  6. Market Summary • Further key findings from the report suggest • In December 2019, UCB and Accenture made an announcement about signing of a partnership agreement to build a safety solution on INTIENT™ pharmacovigilance, by Accenture, to accelerate patient safety case reports’ processing. The agreement is intended to help UCB in discovering the influence of existing treatments on patient’s safety and therefore managing the novel drugs’ risk in a better way. • Spontaneous reporting is a crucial type in pharmacovigilance by providing information from real clinical settings in the course of a drug’s life. Physicians and many other healthcare specialists contribute immensely to improving public health by supposed adverse drug reactions’ reporting. • Several firms support in-house reporting management to healthcare authorities, as in-house reporting is possibly the major contact entity for any kind of in and out deliberation. • . • Request Free Sample https://www.emergenresearch.com/request-sample/81 www.emergenresearch.com

  7. Market Summary • Some Key Highlights From the Report • The escalating sophistication of biologics & therapeutic agents and the growing deployment of novel agents makes it essential to identify any undesired and unforeseen adverse events and other toxicities as early as possible. Popular instances associated with the withdrawal of a drug from the market after receiving sanction, verify Phase IV pharmacovigilance requirement. • Hospital pharmacists are indispensable in reporting adverse drug reactions, as many adverse drug events occur in hospitals, with adverse drug reactions being accountable for a substantial proportion of hospitalizations. • The APAC region's pharmacovigilance market is anticipated to have the fastest CAGR of 13.7% in the period 2020-2027, due to strict legislative regulations for ADR reporting and several firms offering outsourcing services pharmacovigilance. Besides, increased clinical trials’ funding is causative of driving pharmacovigilance market demand in the region. • Key players in market include ArisGlobal, Accenture, Cognizant, Capgemini, IBM Corporation, IQVIA, BoClinica Inc., Laboratory Corporation of America Holdings, LinicalAccelovance, and ITClinical, among others. • Request Free Sample Copy@https://www.emergenresearch.com/request-sample/81 www.emergenresearch.com

  8. Market Summary • Emergen Research has segmented the global pharmacovigilance on the basis of type, service provider, clinical trial phase, end-users, and region: • Type Outlook (Revenue, USD Million; 2017-2027) • Spontaneous Reporting • Intensified Adverse Drug Reaction (ADR) Reporting • Targeted Spontaneous Reporting • Cohort Event Monitoring • Electronic Health Record (HER) Mining • Service Provider Outlook (Revenue, USD Million; 2017-2027) • In-House • Contract Outsourcing • Read More@https://www.emergenresearch.com/industry-report/pharmacovigilance-market

  9. Market Summary • Clinical Trial Phase Outlook (Revenue, USD Million; 2017-2027) • Pre-Clinical • Phase I • Phase II • Phase III • Phase IV • End-Users Outlook (Revenue, USD Million; 2017-2027) • Hospitals • Research Organizations • Others • Read more: https://www.emergenresearch.com/industry-report/pharmacovigilance-market

  10. MARKETSEGMENTATION www.emergenresearch.com

  11. Regional Share Dynamics www.emergenresearch.com

  12. LATEST PUBLICATIONS RELATED REPORTS: Precision Medicine Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market Precision Medicine Market:  https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market Non-Invasive Prenatal Testing Market:    https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market www.emergenresearch.com

  13. About Us At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize on to stay ahead of your competitors. www.emergenresearch.com

  14. Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. 14671 110 Avenue, Surrey, British Columbia, V3R2A9 www.emergenresearch.com www.emergenresearch.com sales@emergenresearch.com +1 (604) 757-9756

More Related